Odylia Therapeutics
Bringing life changing treatments to people with genetic disease, regardless of prevalence or commercial interest
Bringing life changing treatments to people with genetic disease, regardless of prevalence or commercial interest
Odylia Therapeutics is a biotechnology startup that aims to bring life-changing treatments to people with genetic diseases, irrespective of prevalence or commercial interest. The company's unique, nonprofit business model is designed to accelerate the development of gene therapies for individuals with rare diseases.
From a technological perspective, Odylia Therapeutics has the potential to make substantial contributions to the biotechnology and healthcare industries. As a socially responsible entity, its focus on addressing the needs of those with rare genetic disorders highlights its commitment to making a meaningful impact on healthcare.
With the future in mind, Odylia Therapeutics holds great promise for both investors and individuals affected by rare genetic diseases. However, as the company's founding date, headquarter location, and details regarding its last investment and investors are not provided, further information and developments would be necessary to gauge its overall potential and future prospects.
There is no investment information
No recent news or press coverage available for Odylia Therapeutics.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
